OncoExpress has also become available as a mobile app for both Apple and Android operating systems to enable users to access high level model data from their mobile devices “on-the-go”.
CrownBio has expanded its CVMD services capacity by investing in facilities at the University of Louisiana at Lafayette’s New Iberia Research Center (NIRC), the largest national primate research ce...
Selexis’ proprietary SUREtechnology Platform facilitates the rapid, stable, and cost-effective production of virtually any recombinant protein and provides seamless integration of the biologics dev...
MuBase offers a user-friendly experience while searching a large collection of model data, including tumor pathology, genomic characterization, and in vivo pharmacology data with standard of care a...
CrownBio’s models are unparalleled in their translatability and enable clinically translatable evaluation of therapeutics that target not only kidney complications, but also hyperglycemia in diabet...
Thanks to the new XenoBase feature, users will now be able to directly search and interact with dose response curves and IC50 data for over 290 cell lines.
CrownBio will present new data on the development of preclinical solutions for NASH research, a therapeutic area with a high unmet need of models for pharmacological evaluation.
CrownBio’s ALL and AML patient-derived xenograft (PDX) models of different leukemia subtypes are unique in the commercial world, in that they are validated, stable models with typical leukemia symp...
